Eli Lilly to stop promoting Lartruvo after a follow-up study found it failed to significantly prolong the lives of patients
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lilly's cancer therapy Lartruvo fails study, shares dropEli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an ac...
Read more »
Lilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had wo...
Read more »
Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreCheck out the companies making headlines midday Friday.
Read more »
Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Read more »
Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Read more »
The inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancerEli Lilly's $8 billion bid for Loxo Oncology was negotiated during the 2018 holiday season, so as to make a big splash at a major industry conference.
Read more »
House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Read more »